Open Philanthropy recommended a grant of $1,710,588 over two years to Evotec to support research to develop small-molecule antivirals against henipaviruses that have pandemic potential, such as the Hendra and Nipah viruses.
This grant was funded via Open Philanthropy’s request for proposals through the Pandemic Antiviral Discovery Initiative. It falls within Open Philanthropy’s focus area of scientific research, specifically within its interest in science supporting biosecurity and pandemic preparedness.